T36.2X2A Poisoning by chloramphenicol group, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by chloramphenicol group, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting in poisoning by chloramphenicol or its derivatives during an initial medical encounter. It includes cases where deliberate exposure leads to harmful effects, requiring clinical assessment and management. Documentation should specify the chloramphenicol agent, intentional self-harm intent, and encounter details.

Causes

Intentional self-harm poisoning may result from deliberate overdose or ingestion of chloramphenicol. This can occur due to suicidal ideation, attempts to self-harm, or intentional misuse of the medication. Adverse effects may stem from drug interactions, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

• Prior history of mental health conditions (e.g., depression, anxiety).
• Access to chloramphenicol or related agents.
• Prior self-harm or suicidal behavior.
• Substance use disorders.
• Social or environmental stressors.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., bone marrow suppression).
• Neurologic: Dizziness, confusion, seizures, altered mental status.
• Hematologic: Anemia, leukopenia, thrombocytopenia.

Diagnosis

Diagnosis involves clinical evaluation, patient history, and laboratory testing to confirm chloramphenicol exposure and assess organ function. Toxicology screens may identify the agent, while imaging or other tests evaluate complications. Documentation must clarify intent and encounter type.

Treatment Options

Management focuses on stabilizing the patient, decontamination (if appropriate), and supportive care. Antidotes are not available, so treatment addresses symptoms (e.g., antiemetics, fluids, blood products). Psychiatric evaluation and intervention are critical for intentional self-harm cases.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of care, and underlying health. Early treatment improves outcomes, but severe toxicity (e.g., bone marrow suppression) may lead to long-term complications. Follow-up includes monitoring for organ dysfunction and mental health support.

Complications

• Severe hematologic toxicity (e.g., aplastic anemia).
• Organ failure (e.g., hepatic, renal).
• Neurologic damage (e.g., seizures, coma).
• Persistent mental health issues.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Mental health support and crisis intervention.
• Patient education on medication safety and self-harm risks.
• Collaboration with healthcare providers for at-risk individuals.

When to Seek Professional Help

Seek immediate care for suspected poisoning, especially with intentional self-harm. Signs include altered mental status, severe symptoms, or known exposure. Emergency services or a healthcare provider should be contacted promptly.

Tips for Medical Coders

Document the specific chloramphenicol agent, intent (intentional self-harm), and encounter type (initial) to support accurate coding. Ensure clinical notes clarify the circumstances of exposure and any associated mental health factors.